Non-small Cell Lung Cancer with Leptomeningeal Metastases

• CLINICAL_TRIALS research · 2026-04-09
  Clinical Trial Update: Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases [Phase 4]

  This update covers a Phase 4 trial of lorlatinib in ALK-positive non-small cell lung cancer patients with brain or leptomeningeal metastases…

• CLINICAL_TRIALS trial_result · 2023-11-24
  Clinical Trial Update: Immune Checkpoint Inhibitors Intrathecal Injection in Patients With Leptomeningeal Metastases in NSCLC [Phase 2]

  Phase 2 clinical trial investigating intrathecal administration of immune checkpoint inhibitors for leptomeningeal metastases associated wit…